Fosaprepitant Injection, Powder, Lyophilized, For Solution
Product Images NDC 43598-948

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fosaprepitant (NDC 43598-948). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc.,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Packaging label for Fosaprepitant For Injection 150 mg per vial, sterile lyophilized powder for intravenous use only, to be reconstituted with 5 mL of 0.9% Sodium Chloride for Injection. Label shows storage instructions, single-dose vial use, inactive ingredients, distributor Dr. Reddy's Laboratories Inc., and barcodes.*

FDA Label Image

Label (Label)

Label for Fosaprepitant For Injection, 150 mg per vial, single-dose vial. The label indicates it is a lyophilized powder for intravenous use, with storage instructions and usage warnings. The product is labeled by Dr. Reddy's Laboratories Inc., with a National Drug Code (NDC) of 43598-948.*

FDA Label Image

Structure (Structure)

Chemical structure of Fosaprepitant, showing the molecular arrangement of its components including the fluoro-substituted phenyl ring and trifluoromethyl groups, along with its associated dihydrate moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.